Kanabé is pleased to announce that it has been acquired by EFX Laboratories.

EFx is a privately held cannabis company whose defined business strategy is wellness through cannabis.  EFx is sponsoring a Health Canada submission of one of the first cannabis based Phase I & Phase III Clinical studies measuring cannabis as a viable post-operative treatment.  EFx also currently contract manufactures two piece medical cannabis pills for Broken Coast Cannabis Ltd (“BCC”) and Aphria Inc. (“Aphria”). These pills will be available for sale through BCC’s product web site.

Kanabé will operate as a wholly owned subsidiary under EFX Labs continuing its efforts to build products, brand awareness, and relationships with retailers. EFX will support Kanabe to further developing its formulations, providing cannabinoids, as well as manufacturing through their partnership with Broken Coast Cannabis Ltd.


The acquisition will create a uniquely positioned cannabis company combining science and research-based cannabis formulations and manufacturing with a brand focused on health and wellness and cannabis education for the adult-use market. It is anticipated that EFx will move forward with its science and medical-based philosophy, while Kanabé becomes a house-brand to bring adult-use products to the market.


“Kanabé believes this transaction will bolster our product offering by backing up the product formulations with the Health Canada approved clinical study. With access to EFX’s partnerships we will be able to achieve our goal of getting Kanabé on the shelves. Additionally, Kanabé is working with various  retailers to support cannabis education efforts and build product knowledge for its line of health and wellness products Kanabé is poised and well situated to provide our products in distribution channels overseen by provincial commissions through EFX’s unique partnerships”, said Daniel Laferriere, President and founder of Kanabé Corp.

“We believe the acquisition of Kanabé provides an unparalleled opportunity to join forces with an engaging wellness cannabis brand. Together we look forward to building innovative products and brands all backed by cannabis science”, said Michael Kohut, CEO of Efx Laboratories Inc.

For more on Kanabé Goods Co. visit www.kanabe.ca

For more on EFX Laboratories visit www.efxlabs.ca